Serum-free light chains as a dependable biomarker for stratifying patients with metabolic dysfunction-associated steatotic liver disease.
Antonio LiguoriFrancesca D'AmbrosioCecilia NapodanoVanessa GentiliMaria Cristina GiustinianiMaurizio PompiliAntonio GriecoGianludovico RapacciniAndrea UrbaniAntonio GasbarriniUmberto BasileLuca Mielenull nullPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
sFLCs could be a simple biomarker for stratification of cACLD in MASLD patients.